12th December, 2013 -- mehealth™ for ADHD, a software tool developed by Dr Jeff N. Epstein and his colleagues at the world-renowned Cincinnati Children's Hospital in conjunction with Optimal Medicine, launches today.

mehealth™ for ADHD is designed to help clinicians provide high quality ADHD care. This is achieved by closer monitoring of patient outcomes, improved communication with parents and teachers, and faster assessments and turnaround times.

The authors of a large randomized trial, involving over 700 patient charts, concluded that the product is: “A quality improvement intervention that … significantly improved the quality of ADHD care in community-based pediatric settings.”

Survey results included:

- 93 per cent of physicians reported that they were satisfied or very satisfied with the software

- 96 per cent of physicians reported that they would recommend the software to other physicians

Use of the software significantly improved uptake of American Academy of Pediatrics (APP) recommended care practices, including the collection of parent and teacher rating scales.

Other key benefits of the product are that it enables quicker and more accurate billing, and it contributes to American Board of Pediatrics Maintenance of Certification (part 4) credits and 20 performance improvement credits, as recognized by the American Medical Association.

Dr Janet Munro, Chief Executive Officer at Optimal Medicine, comments: “As clinicians we understand that practice guidelines are valuable in supporting the best possible clinical care. However, research shows that AAP guidelines, for the care of children with ADHD, are not being applied reliably due to implementation challenges.” Munro continues: “Taking this into consideration, mehealth™ for ADHD has been developed and successfully facilitates best practice care for each individual child, by supporting clinicians in the challenges they face with diagnosis, treatment and monitoring.”

mehealth™ for ADHD provides clinical decision support that enables clinicians to deliver individualized quality care, and optimize clinical outcomes, for children with ADHD.

mehealth™ for ADHD is a product of Optimal Medicine Inc., a personalized medicine company. Optimal Medicine Inc. is devoted to developing comprehensive suites of clinical decision support software to improve efficiency and clinical outcomes, whilst assisting physicians in the delivery of consistent, high quality, individualized care. Located in Marlborough, Massachusetts (USA), www.optimalmedicine.com

For more information regarding mehealth™ for ADHD please visit: www.mehealthom.com/adhd/

You can also connect with us on Twitter and LinkedIn, as well as getting all the latest industry related news and information via our blog.

PRFilter is a relevance engine that filters press releases for users based on a personal profile of their interests created from their own, or their publication's, published articles. The public website also provides anyone with the ability to search thousands of releases from multiple sources or view the most relevant releases in particular areas of interest.

Releases marked with [PRFilter] in the subject line of RealWire release emails indicate PRFilter determined the release passed an individuals relevance threshold. Users can login and increase or decrease this threshold. Users can also train PRFilter to determine release relevance more accurately by providing feedback – “More”, this release is relevant or “Less”, this release is not relevant.

Please visit PRFilter to log in or contact RealWire for more information.

News Receiver Options

Receivers members area – the receivers members area allows you to amend your news category options and preferences, and access your own personal RSS feed of relevant news. Log in now or request log in details.

Unsubscribe – should you wish to unsubscribe from RealWire’s distribution, please click here. We would very much value your feedback on why you wish to be removed in order for us to continue to improve and develop our service.

Disclaimer:

Whilst RealWire Limited endeavour to ensure the accuracy of the information contained in this Release, RealWire Limited cannot accept any liability for:-

• the inaccuracy or otherwise of any information contained in this Release; or

• any loss liability or expense which may be suffered by any party in consequence of acting or omitting to act as a result of any information contained in or omitted from this Release; or

• any loss or suffering which may be caused by or to any party either as a result of the information contained in this Release or such information contained in this Release being inaccurate or otherwise misleading.

In the event that any information contained in this Release is inaccurate or misleading then please contact RealWire.